- Recent Funding
- Investors
- Euclidean Capital
Euclidean Capital portfolio
Euclidean Capital has 10 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.
About this page
Its most recent investment on record is Setara Biosciences's $90M Series A round in October 2026, alongside EcoR1 Capital, Jazz Pharmaceuticals, Droia Ventures and 3 others. By category, its portfolio leans toward Health and bio (5) and Sales and marketing (2). It has co-invested with Deerfield, Droia Ventures and Canaan Partners, most often Deerfield (3 rounds).
What Euclidean Capital invests in
- Health and bio · 5 · 50%
- Sales and marketing · 2 · 20%
- Fintech · 2 · 20%
- Climate and energy · 2 · 20%
- Consumer and social · 1 · 10%
- Manufacturing and industrial · 1 · 10%
- Robotics and hardware · 1 · 10%
- Developer tools and cloud · 1 · 10%
Euclidean Capital recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series A · $90M | EcoR1 Capital, Jazz Pharmaceuticals, Droia Ventures +3 | ||
| Series B+ · $72M | Brewer Lane Ventures, Vamsi Yadlapati, Thrive Capital +5 | ||
| Series B+ · $66M | Droia Ventures, Regeneron Ventures (lead), Deerfield (lead) +1 | ||
| Series A · $68M | Samsara Biocapital, Sanofi Ventures, The Column Group (lead) | ||
| Series B+ · $100M | Blumberg, Union Tech Ventures, Team8 +3 | ||
| Series A · $75M | Hillspire, LG Energy Solution (lead) | ||
| Series A · $55M | EcoR1 Capital, Droia Ventures (lead), Deerfield +1 | ||
| Series B+ · $55M | Hearst Ventures, Upfront Ventures, Valor Equity Partners (lead) +2 |
How Euclidean Capital invests
Euclidean Capital portfolio companies
SSetara Biosciences$90MSeries A · Oct 2026
SSavvy Wealth$72MSeries B+ · Jul 2025
AActio Biosciences$66MSeries B+ · Jun 2025
NNura Bio$68MSeries A · Sep 2024
FFundGuard$100MSeries B+ · Mar 2024
SSion Power$75MSeries A · Jan 2024
ZZeitview$55MSeries B+ · Feb 2023
AASAPP$120MSeries B+ · May 2021
AA2 Biotherapeutics$71.5MSeries B+ · Oct 2020
TTriGemX Biobacker
| Company | Round with Euclidean Capital | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $90M | $90M | Oct 30, 2026 Series A |
Sales and marketing |
Series B+ · $72M | $216.8M | Sep 9, 2026 Series B+ |
Health and bio |
Series B+ · $66M | $121M | Jun 18, 2025 Series B+ |
Health and bio |
Series A · $68M | $141.8M | Jun 22, 2026 Series B+ |
Fintech |
Series B+ · $100M | $156M | Mar 25, 2024 Series B+ |
Climate and energy |
Series A · $75M | $75M | Jan 29, 2024 Series A |
Robotics and hardware |
Series B+ · $55M | $115M | Mar 4, 2025 round |
AI agents |
Series B+ · $120M | $310M | Jan 7, 2025 Series B+ |
Health and bio |
Series B+ · $71.5M | $270.5M | Jan 10, 2025 Series B+ |
Health and bio |
backer | $94M | Oct 1, 2026 round |
Most frequent co-investors
DDeerfield3 shared rounds · last Oct 30, 2026
DDroia Ventures3 shared rounds · last Oct 30, 2026
CCanaan Partners3 shared rounds · last Oct 30, 2026
EEcoR1 Capital2 shared rounds · last Oct 30, 2026
RRegeneron Ventures2 shared rounds · last Oct 30, 2026
SSamsara Biocapital2 shared rounds · last Sep 18, 2024
TThe Column Group2 shared rounds · last Sep 18, 2024
TTitanium Ventures2 shared rounds · last May 1, 2021
EEmergence Capital2 shared rounds · last May 1, 2021
JJohn Doerr2 shared rounds · last May 1, 2021
HHOF Capital2 shared rounds · last May 1, 2021
JJohn Chambers2 shared rounds · last May 1, 2021
Similar investors
SSR One10 companies · 6 deals in 12 mo
MMurex Partners10 companies · 4 deals in 12 mo
DDeep Track Capital10 companies · 3 deals in 12 mo
MMarshall Wace10 companies · 3 deals in 12 mo
BBlueYard Capital10 companies · 2 deals in 12 mo
DDecheng Capital11 companies · 6 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 11 rounds on Recent Funding that name Euclidean Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Euclidean Capital, which is a subset of its real portfolio. API: /api/v1/investors/euclidean-capital (get a free API key). More: the most active VC firms and new venture capital funds.